120
Participants
Start Date
December 2, 2024
Primary Completion Date
March 1, 2026
Study Completion Date
November 1, 2026
Surveys completion
Completion of surveys: the Feasibility of Implementation Measure (FIM), the Acceptability of Intervention Measure (AIM), the Intervention Appropriateness Measure (IAM), a Likert scale, the EQ-5D-5L questionnaire, the HIV/AIDS-Targeted Quality of Life (HAT-QoL) questionnaire and the HIV Treatment Satisfaction Questionnaire (HIVTSQ).
Home administration of CAB+RPV
Drug treatment and follow-up at home (home arm).
Hospital administration of CAB+RPV
Drug treatment and follow-up in hospital (hospital arm)
RECRUITING
IRCCS San Raffaele Scientific Institute, Milan
Collaborators (1)
GlaxoSmithKline
INDUSTRY
IRCCS San Raffaele
OTHER